Content about Biopharmaceuticals

February 28, 2013

Biosimilar medicines have been approved and routinely prescribed in Europe for nearly seven years, and creation of a clear pathway for Food and Drug Administration review and approval of generic versions of bioengineered drugs was enshrined into law in the United States with the passage of the Patient Protection and Affordable Care Act nearly three years ago.

October 31, 2012

Sandoz starts phase-3 trial of biosimilar anemia drug

Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.

June 7, 2012

Perrigo wins approval for renal failure drug

The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.

April 18, 2011

Keryx, Torii commence phase-3 trial for Zerenex in Japan

A U.S. drug maker and its Japanese partner have started a late-stage clinical trial of a drug for treating elevated phosphate levels in the body, the two announced Monday.

March 7, 2011

Keryx to present phase-3 clinical data for Zerenex at conference

Late-stage clinical trial data for a Keryx Biopharmaceuticals drug to treat kidney disease will be presented at a medical conference in Las Vegas.

December 1, 2010

Keryx: Zerenex reduces phosphate levels in patients on kidney dialysis

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

October 25, 2010

Keryx to commence phase-3 trial for Zerenex

Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a...

August 9, 2010

GSK to pay Nabi third milestone for PentaStaph

Nabi Biopharmaceuticals will receive an $8 million payment from British drug maker GlaxoSmithKline following a...